Immunoelectron microscopic localization of the 210,000-mol wt microtubule-associated protein in cultured cells of primates.
Results from ultrastructural immunocytochemistry on glutaraldehyde-fixed cells confirmed and extended findings previously obtained with immunofluorescence. A microtubule-associated protein (MAP) of 210,000 molecular weight was shown to be specifically associated with all cytoplasmic and mitotic microtubules along their entire length in primate cells. Specific labeling with the anti-MAP antibody could not be detected on any other subcellular structures, notably the centrosomes, kinetochores, microfilaments, and intermediate filaments. Treatment with the microtubule-disrupting drug, nocodazole, induced diffusion of the MAP throughout the cytoplasm. During repolymerization of microtubules following disassembly by nocodazole, the association of the MAP with the microtubules was intermediate and complete. When cells were treated with vinblastine, the tubulin paracrystals formed were heavily stained by the antibody. Neither sodium azide nor taxol affected the association of the MAP with microtubules.
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D001386:Azides / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology; D002219:Carbamates / Q000494:pharmacology; D002460:Cell Line; D002502:Centrioles / Q000032:analysis; D002522:Chlorocebus aethiops; D003599:Cytoskeleton / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D007399:Interphase; D007614:Macropodidae; D051379:Mice; D008854:Microscopy, Electron; D008869:Microtubule-Associated Proteins; D008870:Microtubules / Q000032:analysis*; D008938:Mitosis; D015739:Nocodazole; D017239:Paclitaxel; D011506:Proteins / Q000032:analysis*; D019810:Sodium Azide; D014747:Vinblastine / Q000494:pharmacology
D000470:Alkaloids; D001386:Azides; D001562:Benzimidazoles; D002219:Carbamates; D008869:Microtubule-Associated Proteins; D011506:Proteins; D014747:Vinblastine; D019810:Sodium Azide; D017239:Paclitaxel; D015739:Nocodazole